Literature DB >> 12890679

Roles for homotypic interactions and transautophosphorylation in IkappaB kinase beta IKKbeta) activation [corrected].

Eric D Tang1, Naohiro Inohara, Cun-Yu Wang, Gabriel Nuñez, Kun-Liang Guan.   

Abstract

The nuclear factor kappaB (NF-kappaB)/Rel family of transcription factors participates in a wide range of biological activities including inflammation, immunity, and apoptosis. NF-kappaB is kept inactive in the cytoplasm in unstimulated cells by virtue of the masking of its nuclear localization sequence by bound IkappaB protein. Cellular stimuli trigger the destruction of IkappaB proteins and the liberation of NF-kappaB to enter the nucleus and activate gene expression. A multisubunit IkappaB kinase complex (IKK) phosphorylates IkappaB proteins and mediates the activation of NF-kappaB by proinflammatory stimuli such as tumor necrosis factor alpha. Phosphorylation of IkappaB proteins triggers their polyubiquitination and their subsequent recognition and degradation by the proteasome. The IKK complex contains two catalytic subunits, IKKalpha and IKKbeta, and a noncatalytic subunit, NF-kappaB essential modifier/IKKgamma. IKK activation depends upon the phosphorylation of residues in the activation loop of IKKbeta and the subsequent activation of IKKbeta kinase activity. However, the events contributing to IKKbeta phosphorylation are not well understood. Here, we present evidence that the activation of IKKbeta depends on its ability to form homotypic interactions and to transautophosphorylate. We find that an intact leucine zipper in IKKbeta is necessary for homotypic interactions, kinase activation, and phosphorylation on its activation loop. Enforced oligomerization of an IKKbeta mutant defective in forming homotypic interactions restores kinase activation. Homotypic interactions allow IKKbeta molecules to transautophosphorylate one another on their activation loops. Finally, the oligomerization of IKKbeta is stimulated by tumor necrosis factor alpha in cultured cells. Our findings support a model whereby ligand-induced homotypic interactions between IKKbeta molecules result in IKKbeta phosphorylation and consequently IKK activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890679     DOI: 10.1074/jbc.M304374200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

2.  Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1).

Authors:  Qiutang Li; Qingxian Lu; Virginie Bottero; Gabriela Estepa; Lisa Morrison; Frank Mercurio; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

3.  Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death.

Authors:  Dirk Brenner; Alexander Golks; Friedemann Kiefer; Peter H Krammer; Rüdiger Arnold
Journal:  EMBO J       Date:  2005-12-08       Impact factor: 11.598

Review 4.  NF-κB regulation: lessons from structures.

Authors:  Gourisankar Ghosh; Vivien Ya-Fan Wang; De-Bin Huang; Amanda Fusco
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

5.  MMB triazole analogs are potent NF-κB inhibitors and anti-cancer agents against both hematological and solid tumor cells.

Authors:  Venumadhav Janganati; Jessica Ponder; Meenakshisundaram Balasubramaniam; Poornima Bhat-Nakshatri; Eli E Bar; Harikrishna Nakshatri; Craig T Jordan; Peter A Crooks
Journal:  Eur J Med Chem       Date:  2018-08-10       Impact factor: 6.514

6.  A splicing variant of NME1 negatively regulates NF-κB signaling and inhibits cancer metastasis by interacting with IKKβ.

Authors:  Dong-Joo You; Cho Rong Park; Hyun Bok Lee; Mi Jin Moon; Ju-Hee Kang; Cheolju Lee; Seong-Hyun Oh; Curie Ahn; Jae Young Seong; Jong-Ik Hwang
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

7.  TRAF5 is a downstream target of MAVS in antiviral innate immune signaling.

Authors:  Eric D Tang; Cun-Yu Wang
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

Review 8.  The IkappaB kinase complex: master regulator of NF-kappaB signaling.

Authors:  Laura A Solt; Michael J May
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

9.  Chronic NF-kappaB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response.

Authors:  Christina Batsi; Soultana Markopoulou; George Vartholomatos; Ioannis Georgiou; Panagiotis Kanavaros; Vassilis G Gorgoulis; Kenneth B Marcu; Evangelos Kolettas
Journal:  Mech Ageing Dev       Date:  2009-05-03       Impact factor: 5.432

10.  IKBKG (nuclear factor-kappa B essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function.

Authors:  Bryn H Salt; Julie E Niemela; Rahul Pandey; Eric P Hanson; Raquel P Deering; Ralph Quinones; Ashish Jain; Jordan S Orange; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2008-01-07       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.